Drugs / CYT005-AllQbG10
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00293904 | Feb 2006 → Feb 2007 | hypersensitivity reaction disease | Cytos Biotechnology AG | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00574704 | Sep 2006 → Mar 2008 | house allergic alveolitis, perennial allergic rhinitis | Cytos Biotechnology AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CYT005-AllQbG10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00293904 ↗ |
| Modality | Vaccine | “Allergen Vaccine” NCT00293904 ↗ |